Doctor of Osteopathy Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jerin George

Cardiovascular Disease Carmel, IN Doctor of Osteopathy

NPI 1205367596 CMS profile 8770235

10590 N Meridian St, Carmel, IN 46290

Open in the dashboard

General payments

$75,553

335 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jerin George of Carmel, IN is reported in the CMS Open Payments database as having received $75,553 across 335 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $34,845 118
2024 General $30,535 119
2023 General $5,027 50
2022 General $2,573 19
2021 General $2,573 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jerin George
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to Jerin George were reported at $34,845. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year Jerin George Cardiovascular Disease median Middle half National median
2019 $0 $450 $127–$1,392 $163
2020 $0 $242 $77–$751 $114
2021 $2,573 $335 $101–$1,037 $132
2022 $2,573 $395 $121–$1,211 $149
2023 $5,027 $443 $136–$1,283 $160
2024 $30,535 $450 $136–$1,323 $164
2025 $34,845 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $31,492 125 payments
  2. Medtronic, Inc. $27,756 112 payments
  3. Boston Scientific Corporation $8,695 15 payments
  4. Biotronik Inc. $2,573 20 payments
  5. Biosense Webster, Inc. $2,287 22 payments
  6. Philips Electronics North America Corporation $1,118 7 payments
  7. Medical Device Business Services, Inc. $830 15 payments
  8. Impulse Dynamics (USA) Inc. $286 3 payments
  9. Abiomed $129 1 payment
  10. Pfizer Inc. $88 4 payments
  11. Other $301 11 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Grant $38,000 7 payments
  2. Travel and Lodging $21,442 91 payments
  3. Food and Beverage $14,850 229 payments
  4. Education $1,262 8 payments
Products named General payments · program years 2021–2025
  1. EMBLEM MRI S-ICD $5,000 1 payment
  2. ENSITE $4,026 34 payments
  3. Carto 3 $2,981 36 payments
  4. ENSITE PRECISION $2,720 19 payments
  5. ASSURITY $2,250 1 payment
  6. TACTICATH $2,250 1 payment
  7. EnSite Precision Cardiac Mapping System $2,101 17 payments
  8. Micra $1,691 13 payments
  9. GALLANT Cardiac Rhythm Management $1,093 10 payments
  10. GALLANT Structural Heart $1,077 2 payments
  11. Other $7,276 86 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

335 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record